VolitionRx Ltd
VNRX
34 hedge funds and large institutions have $8.99M invested in VolitionRx Ltd in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 6 closing their positions.
1,271% more call options, than puts
Call options by funds: $192K | Put options by funds: $14K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0.51% → 0.51% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
11% less funds holding
Funds holding: 38 → 34 (-4)
26% less capital invested
Capital invested by funds: $12.2M → $8.99M (-$3.23M)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$284K |
| 2 |
LIM
Lagoda Investment Management
New York
|
+$253K |
| 3 |
DI
DFPG Investments
Sandy,
Utah
|
+$41.4K |
| 4 |
BlackRock
New York
|
+$33.3K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$23.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$186K |
| 2 |
Cerity Partners
New York
|
-$124K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$98.7K |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$57.6K |
| 5 |
Jane Street
New York
|
-$50K |
VNRX Hedge Fund Activity: Q2 2023 in Review
34 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q2 2023, worth a combined $8.99M — down 26% from $12.2M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of VNRX and 2 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 8 added.
The largest buyer was Geode Capital Management, adding an estimated $284K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $186K sold.
- 34 institutional investors held VolitionRx Ltd (VNRX) as of Q2 2023, down from 38 in Q1 2023.
- Funds reported $8.99M of VolitionRx Ltd stock for Q2 2023, down 26% quarter-over-quarter.
- 2 funds opened new VolitionRx Ltd positions in Q2 2023 and 6 closed out, a net change of -4 holders.
- The largest VolitionRx Ltd buyer in Q2 2023 was Geode Capital Management, an estimated $284K added.
- The largest VolitionRx Ltd seller in Q2 2023 was Susquehanna International Group, an estimated $186K sold.
Based on aggregated 13F filings for Q2 2023.